Survey shock for pharma
February 4, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, PACE, lilly, pharma, research
A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …
NHS Commissioning Board executive departs
February 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Dalton, NHS
The NHS Commissioning Board has announced the forthcoming departure of its chief operating officer and deputy chief executive. Ian Dalton …
Lewisham A&E spared axe
February 1, 2013Sales and Marketing Hunt, Lewisham, Miliband, NHS
The government’s threat to close Lewisham Hospital’s A&E unit has been lifted after health secretary Jeremy Hunt decided to cut …
NICE rejects Forxiga
February 1, 2013Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes
NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …
Novo Nordisk creates four senior vice presidents
February 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk
Novo Nordisk has promoted four corporate vice presidents within its ranks into senior vice presidents. The following members of the US …
GSK slams Guardian article
January 31, 2013Sales and Marketing Avandia, FDA, GSK, Guardian
GlaxoSmithKline has slammed an article about its controversial diabetes treatment Avandia in The Guardian newspaper, saying that some of it …
NHS expertise sold abroad
January 31, 2013Sales and Marketing NHS, UK, government, outsourcing
The government has set up an organisation which will seek to maximise revenue from foreign firms and governments for the …
Lilly hit by Zyprexa losses
January 30, 2013Sales and Marketing antipsychotic, lilly, zyprexa
The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …
EMA starts contraceptive safety review
January 30, 2013Manufacturing and Production, Sales and Marketing EMA, PRAC, VTE, contraception
Europe’s health regulator is to examine the safety of newer forms of contraceptive pills following concerns over potential health risks …
Merck signs lupus research deal
January 30, 2013Research and Development, Sales and Marketing Feinstein, Merck Serono, SLE
Merck Serono and the Feinstein Institute for Medical Research in New York are to collaborate on antibodies to treat systemic …
Oxyrane brings on board senior team
January 30, 2013Manufacturing and Production, Research and Development, Sales and Marketing Oxyrane, biotech
UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …
Succinct and Royal Marsden launch new partnership
January 29, 2013Medical Communications, Research and Development, Sales and Marketing NHS, Succinct, royal marsden
Communications agency Succinct has unveiled a new innovative NHS/industry partnership with The Royal Marsden hospital, one of Europe’s leading cancer …
AstraZeneca signs respiratory deal
January 29, 2013Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory
AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …
Payments register moves closer
January 29, 2013Sales and Marketing Bad pharma, Goldacre, NHS, doctors, pharma
Greater transparency around the payments made by pharma companies to doctors looks to have moved a step closer with a …
Lonza says 2012 growth was solid, but more restructuring due
January 29, 2013Manufacturing and Production Arch, CMO, Lonza
Swiss contract manufacturing organisation (CMO) and ingredients supplier Lonza posted a 46% increase in revenues to 3.93 billion francs last …
Synthon opens ADC plant in the Netherlands
January 29, 2013Manufacturing and Production ADC, Synthon
Synthon Biopharmaceuticals says it has opened officially opened a new antibody-drug conjugate (ADC) manufacturing facility in Nijmegen, the Netherlands. The …
Boehringer calls for ‘game changing’ ideas in health
January 29, 2013Medical Communications, Research and Development, Sales and Marketing Ashoka Changemakers, Boehringer Ingelheim
Boehringer Ingelheim has teamed up with a social entrepreneur network to promote health projects in developing countries. This is the …
New government chairman for pharmacy programme board
January 29, 2013Manufacturing and Production, Medical Communications, Sales and Marketing Ken Jarrold, NHS, government
The Department of Health has announced the appointment of Ken Jarrold to chair the programme board for the government’s work …
NICE hits back at ‘limited’ EC study
January 28, 2013Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead
NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …
Takeda gets US diabetes approval
January 28, 2013Sales and Marketing FDA, Nesina, Takeda, diabetes
Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
